Roots announced that its newly validated Accelerator is now available to Guidewire ClaimCenter users on Guidewire Cloud via the Guidewire ...
Enliven Therapeutics, Inc. (Enliven or the Company) , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the ...
Investor's Business Daily on MSN
Silicon Labs sees AI moving to the intelligent edge
Silicon Labs is poised to benefit as AI processing moves from data centers to embedded devices on the edge of networks.
Zacks Investment Research on MSN
Is it the right time to add Insulet stock to your portfolio?
Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...
In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last closing at $66.54 after mixed short term and ...
When you're a business owner, it's hard to be everywhere at once — even though, your venture kind of demands it of you, especially if you're a solopreneur. Luckily, there are lots of tools on the ...
SINGAPORE - Patients with rarer types of diabetes, including those caused by cancer, can now benefit from government subsidies of up to 80 per cent, which would almost halve their monthly costs spent ...
In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results